Carregant...
A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma
Immunotherapy presents a new promising approach to the treatment of disseminated lung cancer. Pemriblisumab (Kitruda®) is one of the antiPD-1 drugs registered in Russia, which is used in both the secondand, in the event of high-level PD-L1 expression (≥50%), the first-line therapy. This paper presen...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Remedium Group LLC
2018-07-01
|
| Col·lecció: | Медицинский совет |
| Matèries: | |
| Accés en línia: | https://www.med-sovet.pro/jour/article/view/2526 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|